These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 10583119)

  • 1. Measuring health-related quality of life in patients with mild to moderate eczema and psoriasis: clinical validity, reliability and sensitivity to change of the DLQI. The Cavide Research Group.
    Badia X; Mascaró JM; Lozano R
    Br J Dermatol; 1999 Oct; 141(4):698-702. PubMed ID: 10583119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Assessment on the reliability and validity of the Dermatology Life Quality Index in Chinese version].
    Wang XL; Zhao TE; Zhang XQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Sep; 25(9):791-3. PubMed ID: 15555362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study.
    Shikiar R; Willian MK; Okun MM; Thompson CS; Revicki DA
    Health Qual Life Outcomes; 2006 Sep; 4():71. PubMed ID: 17005043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychometric properties of the Chinese version of Dermatology Life Quality Index (DLQI) in 851 Chinese patients with psoriasis.
    He Z; Lu C; Basra MK; Ou A; Yan Y; Li L
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):109-15. PubMed ID: 22145712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity and reliability of patient reported outcomes used in psoriasis: results from two randomized clinical trials.
    Shikiar R; Bresnahan BW; Stone SP; Thompson C; Koo J; Revicki DA
    Health Qual Life Outcomes; 2003 Oct; 1():53. PubMed ID: 14613569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring quality of life in patients with psoriasis using the Arabic version for Morocco of the Dermatology Life Quality Index.
    Khoudri I; Lamchahab FZ; Ismaili N; Senouci K; Hassam B; Abouqal R
    Int J Dermatol; 2013 Jul; 52(7):795-802. PubMed ID: 23488573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement Properties of the Psoriasis Symptom Inventory Electronic Daily Diary in Patients with Moderate to Severe Plaque Psoriasis.
    Viswanathan HN; Mutebi A; Milmont CE; Gordon K; Wilson H; Zhang H; Klekotka PA; Revicki DA; Augustin M; Kricorian G; Nirula A; Strober B
    Value Health; 2017 Sep; 20(8):1174-1179. PubMed ID: 28964451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric properties of the Dermatology Life Quality Index (DLQI) in 900 Italian patients with psoriasis.
    Mazzotti E; Barbaranelli C; Picardi A; Abeni D; Pasquini P
    Acta Derm Venereol; 2005; 85(5):409-13. PubMed ID: 16159732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a new tool to assess health-related quality of life in psoriasis: the PSO-LIFE questionnaire.
    Dauden E; Herrera E; Puig L; Sánchez-Carazo JL; Toribio J; Caloto MT; Nocea G; Roset M; Lara N
    Health Qual Life Outcomes; 2012 May; 10():56. PubMed ID: 22624984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the French version of the arthritis impact measurement scales 2 and comparison with the french version of the Nottingham Health Profile. "Quality of Life in Rheumatology" Task Force.
    Pouchot J; Guillemin F; Coste J; Brégeon C; Sany J
    Rev Rhum Engl Ed; 1996 Jun; 63(6):389-404. PubMed ID: 8817749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability and convergent and discriminant validity of the Child Oral Health Impact Profile (COHIP Child's version).
    Broder HL; Wilson-Genderson M
    Community Dent Oral Epidemiol; 2007 Aug; 35 Suppl 1():20-31. PubMed ID: 17615047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease.
    Basra MK; Sue-Ho R; Finlay AY
    Br J Dermatol; 2007 Mar; 156(3):528-38. PubMed ID: 17300244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial.
    Lebwohl M; Papp K; Han C; Schenkel B; Yeilding N; Wang Y; Krueger GG
    Br J Dermatol; 2010 Jan; 162(1):137-46. PubMed ID: 19903183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Norwegian version of the dermatology life quality index: a study of validity and reliability in psoriatics.
    Mørk C; Wahl A; Moum T
    Acta Derm Venereol; 2002; 82(5):347-51. PubMed ID: 12430733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the use of the dermatology life quality index as a criterion in clinical guidelines and health technology assessments in psoriasis and chronic hand eczema.
    Basra MK; Chowdhury MM; Smith EV; Freemantle N; Piguet V
    Dermatol Clin; 2012 Apr; 30(2):237-44, viii. PubMed ID: 22284138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between clinical response to therapy and health-related quality of life outcomes in patients with moderate to severe plaque psoriasis.
    Revicki DA; Willian MK; Menter A; Saurat JH; Harnam N; Kaul M
    Dermatology; 2008; 216(3):260-70. PubMed ID: 18187944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ustekinumab improves health-related quality of life in Korean and Taiwanese patients with moderate to severe psoriasis: results from the PEARL trial.
    Tsai TF; Song M; Shen YK; Schenkel B; Choe YB; Kim NI; Lee JH; Lee JH; Song HJ; Youn JI;
    J Drugs Dermatol; 2012 Aug; 11(8):943-9. PubMed ID: 22859239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of adalimumab treatment on patient-reported outcomes: results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis.
    Revicki DA; Willian MK; Menter A; Gordon KB; Kimball AB; Leonardi CL; Langley RG; Kimel M; Okun M
    J Dermatolog Treat; 2007; 18(6):341-50. PubMed ID: 18058494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement properties of a patient-reported outcome measure assessing psoriasis severity: The psoriasis symptoms and signs diary.
    Mathias SD; Feldman SR; Crosby RD; Colwell HH; McQuarrie K; Han C
    J Dermatolog Treat; 2016 Aug; 27(4):322-7. PubMed ID: 26634943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials.
    McKenna SP; Cook SA; Whalley D; Doward LC; Richards HL; Griffiths CE; Van Assche D
    Br J Dermatol; 2003 Aug; 149(2):323-31. PubMed ID: 12932239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.